COVID-19 vaccine acceptance among high-risk populations in Uganda

37Citations
Citations of this article
230Readers
Mendeley users who have this article in their library.

Abstract

Background: Immunization is an important strategy for controlling the COVID-19 pandemic. COVID-19 vaccination was recently launched in Uganda, with prioritization to healthcare workers and high-risk individuals. In this study, we aimed to determine the acceptability of COVID-19 vaccine among persons at high risk of COVID-19 morbidity and mortality in Uganda. Methods: Between 29 March and 14 April 2021, we conducted a cross-sectional survey consecutively recruiting persons at high risk of severe COVID-19 (diabetes mellitus, HIV and cardiovascular disease) attending Kiruddu National Referral Hospital outpatient clinics. A trained research nurse administered a semi-structured questionnaire assessing demographics, COVID-19 vaccine related attitudes and acceptability. Descriptive statistics, bivariate and multivariable analyses were performed using STATA 16. Results: A total of 317 participants with a mean age 51.5 ± 14.1 years were recruited. Of this, 184 (60.5%) were female. Overall, 216 (70.1%) participants were willing to accept the COVID-19 vaccine. The odds of willingness to accept COVID-19 vaccination were four times greater if a participant was male compared with if a participant was female [adjusted odds ratio (AOR): 4.1, 95% confidence interval (CI): 1.8–9.4, p = 0.00]. Participants who agreed (AOR: 0.04, 95% CI: 0.01–0.38, p = 0.003) or strongly agreed (AOR: 0.04, 95% CI: 0.01–0.59, p = 0.005) that they have some immunity against COVID-19 were also significantly less likely to accept the vaccine. Participants who had a history of vaccination hesitancy for their children were also significantly less likely to accept the COVID-19 vaccine (AOR: 0.1, 95% CI: 0.01–0.58, p = 0.016). Conclusion: The willingness to receive a COVID-19 vaccine in this group of high-risk individuals was comparable to the global COVID-19 vaccine acceptance rate. Increased sensitization, myth busting and utilization of opinion leaders to encourage vaccine acceptability is recommended.

References Powered by Scopus

A global survey of potential acceptance of a COVID-19 vaccine

1896Citations
N/AReaders
Get full text

BNT162B2 mRNA covid-19 vaccine in a nationwide mass vaccination setting

1879Citations
N/AReaders
Get full text

Covid-19 - Navigating the uncharted

1306Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Attitudes, acceptance and hesitancy among the general population worldwide to receive the COVID-19 vaccines and their contributing factors: A systematic review

272Citations
N/AReaders
Get full text

COVID-19 Vaccine Acceptance among Low-and Lower-Middle-Income Countries: A Rapid Systematic Review and Meta-Analysis

99Citations
N/AReaders
Get full text

Systematic Review and Meta-Analysis of COVID-19 Vaccination Acceptance

57Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Bongomin, F., Olum, R., Andia-Biraro, I., Nakwagala, F. N., Hassan, K. H., Nassozi, D. R., … Kirenga, B. J. (2021). COVID-19 vaccine acceptance among high-risk populations in Uganda. Therapeutic Advances in Infectious Disease, 8. https://doi.org/10.1177/20499361211024376

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 46

57%

Lecturer / Post doc 16

20%

Researcher 13

16%

Professor / Associate Prof. 6

7%

Readers' Discipline

Tooltip

Medicine and Dentistry 37

50%

Nursing and Health Professions 19

26%

Social Sciences 11

15%

Agricultural and Biological Sciences 7

9%

Save time finding and organizing research with Mendeley

Sign up for free